Taking Family Cancer History May Release Emotions

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 9
Volume 7
Issue 9

SAN FRANCISCO--A thorough and accurate family history, going back at least four generations, is one of the most effective tools for establishing genetic cancer risk in a patient, Andrea Fishbach, MS, MPH, of Kaiser Permanente, San Francisco, said at the American Cancer Society’s 2nd National Conference on Cancer Genetics. But counselors should be aware that taking such a history can release strong emotions in the patient.

SAN FRANCISCO--A thorough and accurate family history, going back at least four generations, is one of the most effective tools for establishing genetic cancer risk in a patient, Andrea Fishbach, MS, MPH, of Kaiser Permanente, San Francisco, said at the American Cancer Society’s 2nd National Conference on Cancer Genetics. But counselors should be aware that taking such a history can release strong emotions in the patient.

A family history, she said, can reveal much about family dynamics, showing the social relationships within the family and how information flows. "Behind these symbols in the family tree are people and relationships," she said. "You have to remember that during the family history gathering." She recalled one patient who burst into tears after seeing on a chart all the members of her family who had died of cancer. "She had never grieved for them collectively," Ms. Fishbach said.

Other emotional issues may come up during a family history. Patients may be fearful of having a genetic disease, afraid of the social stigma of carrying a cancer gene, or wary of having to make a decision about genetic testing.

It is vital to verify the facts in the history through pathology reports, hospital records, and histologic sections, if available, Ms. Fishbach said, especially concerning the patient’s remote relatives. A 1985 study by Love, for example, found that patients often could name the primary site of their primary relatives’ cancer, but cancer in remote relatives was significantly underreported.

Is Grief Counseling Necessary?

As the patient and clinician delve into the family history, the clinician can identify if genetic counseling is needed and also should consider if grief counseling would be useful. "Often there is grief and guilt about being part of a family with a cancer gene. We want to instill hope with counseling, reinforce coping methods, and teach new ways of coping," Ms. Fishbach said.

Another goal of counseling, she said, is to promote family communication so that each member can make accurate decisions about his or her risk.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
The phase 3 NIVOSTOP trial evaluated an anti–PD-1 immunotherapy, nivolumab, in a patient population similar in the KEYNOTE-689 trial.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
Opportunities to further reduce relapses include pembrolizumab-based combination therapy and evaluating the agent’s contribution before and after surgery.
For patients with locally advanced head and neck cancers, the current standard of care for curative therapy has a cure rate of less than 50%.
According to Maurie Markman, MD, patient-reported outcomes pertain to more relevant questions surrounding the impact of therapy for patients.
CancerNetwork® spoke with Neha Mehta-Shah, MD, MSCI, about the clinical landscape for patients undergoing treatment for rare lymphomas.
Related Content